Associated Papers
Variant-specific functional effects of CTNNA1 in a humanized Drosophila model.
Lobo S et al.
European Journal of Human Genetics : Ejhg, 2026
Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.
Lobo S et al.
Gut, 2025
First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants.
Coudert M et al.
Journal of Medical Genetics, 2022
Novel somatic variants in CTNNA1 gene in Iranian patients with diffuse gastric cancer.
Naghi Vishteh M et al.
Gastroenterology and Hepatology From Bed to Bench, 2021
Variant filtering, digenic variants, and other challenges in clinical sequencing: a lesson from fibrillinopathies.
Najafi A et al.
Clinical Genetics, 2020
31506931 (PubMed )
Supplement: CGE-97-235-s002.xlsx › All_variants_annotated
Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility.
Weren RDA et al.
Journal of Medical Genetics, 2018
29330337 (PubMed )
Supplement: jmedgenet-2017-104962supp001.docx
αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
de Groot JS et al.
The Journal of Pathology, 2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
Ross JS et al.
Cancer, 2018
29338072 (PubMed )
Supplement: CNCR-124-1358-s002.xlsx › Colon
Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network.
Slavin T et al.
Cancer Genetics, 2017
Genetic predisposition to gastric cancer.
Petrovchich I et al.
Seminars in Oncology, 2016
Select a paper to view details